2020
DOI: 10.1080/00397911.2020.1792498
|View full text |Cite
|
Sign up to set email alerts
|

Polyphosphoric acid-promoted synthesis of coumarins lacking substituents at positions 3 and 4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 31 publications
0
7
0
Order By: Relevance
“…At first, to obtain the different coumarin analogues 2a,2b and 3a,3d , the approach based on modified Perkin condensation of salicylaldehyde and acetic anhydride promoted by polyphosphoric acid (PPA) was employed (Scheme 1, Method A). 16 The final products with Br or NO 2 as substituents were obtained in moderate yields.…”
Section: Resultsmentioning
confidence: 98%
See 2 more Smart Citations
“…At first, to obtain the different coumarin analogues 2a,2b and 3a,3d , the approach based on modified Perkin condensation of salicylaldehyde and acetic anhydride promoted by polyphosphoric acid (PPA) was employed (Scheme 1, Method A). 16 The final products with Br or NO 2 as substituents were obtained in moderate yields.…”
Section: Resultsmentioning
confidence: 98%
“…To broaden and systemise the scope of coumarins, classical and/or modified recently published synthetic methodologies were used. However, known methods for the synthesis of the desired 3,4-unsubstituted analogues are very limited, and it can be performed by Perkin condensation 16 and organocatalytic procedures 17 using salicylaldehyde or phenol 18 derivatives as starting materials. At first, to obtain the different coumarin analogues 2a,2b and 3a,3d , the approach based on modified Perkin condensation of salicylaldehyde and acetic anhydride promoted by polyphosphoric acid (PPA) was employed (Scheme 1, Method A).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The target ureidocoumarins 3a–p and 4a–c were synthesized using 6-aminocoumarin 2 as the main component, as shown in Scheme 1 . First, 2-hydroxy-5-nitrobenzaldehyde was converted to 6-nitrocoumarin 1 [ 33 ] by reacting it with acetic anhydride in a mixture of polyphosphoric acid (PPA) and dimethylformamide (DMF) at 145 °C. Then, 1 was reduced to the corresponding amine 2 in good yield by either iron powder in a solution of AcOH:EtOH:water [ 34 ] or SnCl 2 dihydrate in ethanol [ 35 ].…”
Section: Resultsmentioning
confidence: 99%
“…Next, coumarin is one of the key core segments in active pharmaceutical ingredients, bioactive natural and synthetic products [37][38][39]. Compounds having the coumarin scaffold have been illustrated to possess a broad range of biological activities including anti-oxidant [40][41], anti-in ammatory [42][43],…”
Section: Introductionmentioning
confidence: 99%